Karyopharm Therapeutics (KPTI)'s 30-day implied volatility (IV30) was 170.1% at the close on November 4, 2026, up from 164.5% the day before, against a 52-week range of 61.5% to 400.0%. Its 20-day historical volatility was 221.4%.
Data as of November 4, 2026.